When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRTX - Amgen -2.0% after early stage AMG 510 data disappoints
Mirati Therapeutics Inc.
Amgen (NASDAQ:AMGN) moves down 2.0% in premarket trading after disclosing new data from the ongoing early-stage study evaluating AMG 510 in patients with previously treated KRAS G12C-mutant solid tumors.
More news on: Amgen Inc., Mirati Therapeutics, Inc., Stocks on the move, Healthcare stocks news,